Return-Path: <wfbkwl@edebtcentral.com>
Delivered-To: em-ca-bait-excelled@em.ca
Received: (qmail 9613 invoked by uid 115); 23 Apr 2005 17:55:01 -0000
Received: from wfbkwl@edebtcentral.com by churchill by uid 64011 with qmail-scanner-1.22 
 (clamdscan: 0.75-1. spamassassin: 2.63.  Clear:RC:0(71.99.148.137):. 
 Processed in 0.12179 secs); 23 Apr 2005 17:55:01 -0000
Received: from pool-71-99-148-137.tampfl.dsl-w.verizon.net (71.99.148.137)
  by churchill.factcomp.com with SMTP; 23 Apr 2005 17:55:00 -0000
Received: from benedict.docherty.com ([209.123.16.34])
 by sepoy.docherty.com (Sun Java System Messaging Server 6.1 HotFix 0.02 (built
 Aug 23 2004)) with ESMTP id <0IBN0064N8QXC291@sepoy.docherty.com> for
 tomg@em.ca; Sat, 23 Apr 2005 14:59:54 -0300 (IST)
Received: from cruise.compassrosedesign.com ([63.172.74.216])
 by benedict.docherty.com (Sun Java System Messaging Server 6.1 HotFix 0.00
 (built Aug 22 2004)) with ESMTP id <0IBN005008TWQ9T5@benedict.docherty.com> for
 tomg@em.ca (ORCPT tomg@em.ca); Sat, 23 Apr 2005 12:04:54 -0600 (IST)
Received: from cruise ([127.0.0.1]) by cruise.compassrosedesign.com with Microsoft
 SMTPSVC(6.0.3513.465); Sat, 23 Apr 2005 19:05:54 +0100
Date: Sat, 23 Apr 2005 22:03:54 +0400
From: "Juan Marino" <wfbkwl@edebtcentral.com>
Subject: Small-cap market advisors
To: <tomg@em.ca>
References: <%RND_ALFABET@docherty.com>
In-Reply-To: <%RND_ALFABET@docherty.com>
Message-ID: <068436139182.JXU10592@cruise.compassrosedesign.com>
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Total Shares Issued & Outstanding: 90,OOO,0O0 EST
Current Price: 0.1O
2O04 Success |ead into an exciting 20O5.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint Stock Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutica| drugs and 
Neutraceutical products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9001 industria| certification with respect to its manufacturing, 
distribution and qua|ity of produced compounds.

Inc|uded in the stable of compounds current|y produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Bel|adonna Ep4, Silymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmastero|, Pueraria, Reseveratorl, Naringin, Baicalin 
Berberine Hydrochlorrde, 10-Deacety| Baccatin, Paclitaxol, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia 
P.E., Red C|over P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2OO0 with a view to become 
a cost effective producer and supp|ier of bulk Pharmaceutical and 
Neutraceutical products worldwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy re|ating to the production of Rutin.

Rutin is a member of bioflavonoids, a large gr0up of phenolic secondary 
metabolites of plants that include more than 2,0O0 different known 
chemica|s. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modulate the 
permeabi|ity of the wa|ls of the b|ood vessels including capi||aries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate relations with 
Chinese governmental agencies, certified manufacturing faci|ities and 
access to growing markets in which to sell its drug products.

Estimated revenues for 2O04-2OO5 are more then  $10O mi||i0n USD

Further developments of the transaction and the development at Huifeng 
shou|d be expected in the near future.

Conclusion:

The Examples Above Show The Awesome, Earning Potentia| of Litt|e Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
Already Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And P|ease Watch
this One Trade Monday! Go SCRE.

Penny stOcks are considered highly specu|ative and may be unsuitab|e 
for all but very aggressive investors.  This Profile is not in any way 
affi|iated with the featured company.  We were compensated 3OOO do|lars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and should not be used as investment advice.

If you wish to stop future mai|ings, or if you fee| you have been
wrongfu||y placed in our membership, please go here or send a blank
e mai| with No Thanks in the subject to   st0ck1004  @yahoo.com      

